Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities GERN - Geron Corporation
-180 M
LAST VALUE
-87.25%
2 YEAR CAGR
-18.33%
5 YEAR CAGR
-25.33%
10 YEAR CAGR